Journal of Neurovirology

Papers
(The median citation count of Journal of Neurovirology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Possible role of CNS microRNAs in Human Mpox virus encephalitis—a mini-review47
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report46
Zika virus infection of retinal cells and the developing mouse eye induces host responses that contrasts to the brain and dengue virus infection30
Combined effects of older age and HIV disease on changes in everyday functioning over one year23
HIV associated motor neuron disease (MND): A case series with systematic review of literature21
Cognitive function and impact on driving after SARS-COV-2 infection in a man with long-standing HIV infection: a case report19
Serum mir-142-3p release in children with viral encephalitis and its relationship with nerve injury and inflammatory response19
Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients17
Progressive multifocal leukoencephalopathy in sarcoidosis successfully treated with pembrolizumab16
Varicella-zoster virus meningitis coincident with bacteremia caused by liver abscess: a case report15
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats15
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma15
Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women14
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation14
SARS-CoV-2–associated Guillain–Barre syndrome requires extensive pre- and post-mortem examinations14
COVID-19 leukoencephalopathy with subacute magnetic resonance imaging findings of vasculitis and demyelination13
HIV-1 and methamphetamine alter galectins -1, -3, and -9 in human monocyte-derived macrophages13
SARS-CoV-2-associated haemorrhagic encephalitis mimicking Herpes encephalitis13
Improvement in depressive symptoms after antiretroviral therapy initiation in people with HIV in Rakai, Uganda13
Long-term survival from progressive multifocal leukoencephalopathy in living-donor liver transplant recipient with preformed donor-specific antibody12
Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected11
Effect of coinfections on neurocognitive functioning among people with clade C HIV infection in Zambia11
Neurological manifestations of COVID-19 in pregnancy: a cross-sectional study11
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV11
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice11
Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases10
HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis9
Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis9
A human-derived 3D brain organoid model to study JC virus infection9
Upregulation of microRNAs correlates with downregulation of HERV-K expression in Parkinson’s disease9
Cerebrospinal Fluid Biomarkers of Symptomatic Neurosyphilis in People With HIV Compared with Uninfected Individuals9
Herpes simplex encephalitis in patients receiving chemotherapy and whole-brain radiation therapy8
Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases8
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study8
Progressive multifocal leukoencephalopathy and Creutzfeldt-Jakob disease: population-wide incidences, comorbidities, costs of care, and outcomes8
Increased expression of PD-1 in CD8 + CD3 + T cells correlates with EBV viral load in MS patients8
Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good’s syndrome8
Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma8
HIV-associated multiple intracranial aneurysms and stroke in an adult patient: successful treatment with a combination of glucocorticoid and antiviral agents8
Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis7
Simian varicella virus infection and reactivation in rhesus macaques trigger cytokine and Aβ40/42 alterations in serum and cerebrospinal fluid7
In vitro characterization of the antiviral activity of Bat Interferon-Induced protein with tetratricopeptide repeats 5 (bat IFIT5) against bat-associated rabies virus7
Influence of plasma exosomes from women living with HIV Stratified by HAND on monocyte subpopulations from healthy women without HIV7
A case of ischemic stroke secondary to varicella-zoster virus meningoencephalitis7
Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis: a systematic review7
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers7
A rare kind of Guillain-Barre syndrome triggered by acute hepatitis A infection in a pediatric patient: a case report and review of literature6
Cognitive deficits in HTLV-1 patients6
Limited evidence for a moderating effect of HIV status on brain age in heavy episodic drinkers6
Implications of vascular depression for successful cognitive aging in HIV Disease6
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau6
Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus6
The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation6
Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy6
Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications6
Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country6
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system6
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage6
Detection of human neurotropic JCPyV DNA sequence in pediatric anaplastic xanthoastrocytoma6
Catastrophic tumefactive acute disseminated encephalomyelitis in patient with dengue virus: a case report6
Characterizing Epstein-Barr virus infection of the central nervous system in Zambian adults living with HIV6
Myelin regulatory factor is a target of individual and interactive effects of HIV-1 Tat and morphine in the striatum and pre-frontal cortex5
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review5
Differential expression of cellular prion protein (PrPC) in mouse hepatitis virus induced neuroinflammation5
A pilot study of cognition and creativity among persons with HIV disease referred for neuropsychological evaluation5
Maintaining the battle against vaccine-preventable neurological diseases in the United States5
Rapid-progressing progressive multifocal leukoencephalopathy in two patients newly diagnosed with HIV: case series and review of literature5
The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV5
HSV-1 latency-associated transcript miR-H3 and miR-H4 target STXBP1 and GABBR2 genes5
Evaluation of the effects of the Zika Virus-Immunoglobulin G+ complex on murine microglial cells5
Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use5
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis5
The incidence of symptomatic CSF viral escape in patients on antiretroviral therapy in western India: a retrospective cohort study5
Mapping ACE2 and TMPRSS2 co-expression in human brain tissue: implications for SARS-CoV-2 neurological manifestations4
Risk factors for neurological complications in children with Flavivirus infection4
Cooperative interactions between neurotrophin receptors and CXCR4 regulate macrophage phenotype and susceptibility to activation by HIV4
Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases4
Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV4
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology4
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid4
Response to “a fatal case of Guillain-Barré syndrome after infection with COVID-19”4
Extensive longitudinal myelitis due to cytomegalovirus infection4
Hypoactivation in the precuneus and posterior cingulate cortex during ambiguous decision making in individuals with HIV4
Monkeypox virus replication underlying circadian rhythm networks4
Encephalomyelitis in a patient with monkeypox: an unusual complication4
Correction to: TCA cycle metabolic compromise due to an aberrant S‑nitrosoproteome in HIV‑associated neurocognitive disorder with methamphetamine use4
Long-term sequelae of herpes simplex virus encephalitis–related white matter injury: correlation of neuropsychological outcome and diffusion tensor imaging4
T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder4
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV4
Artery of Percheron infarction associated with COVID-19 in the young adult4
Acute cerebellitis following COVID-19 infection associated with autoantibodies to glutamate receptors: a case report3
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder3
Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report3
A frantic confusion: beyond rabies and anti-N-methyl-D-aspartate encephalitis3
Progressive multifocal leukoencephalopathy: a retrospective study of the last 12 years in a tertiary-care hospital3
Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants3
Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV3
Notes from guest editor Dr. Fatah Kashanchi3
Atypical disseminated herpes zoster infections in patients with demyelinating disease treated with dimethyl fumarate3
Sex differences in cognitive function among people with HIV-1 clade C infection in Northern India3
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro3
Amebic infections of the central nervous system3
Differences in neuroinflammation in people who started antiretroviral treatment during primary versus chronic HIV infection: an 18kDa Translocator protein (TSPO) positron emission tomography (PET) stu3
Is there a connection between neurocognitive profile in treatment naïve non-cirrhotic HCV patients and level of systemic inflammation?3
Regulation of voltage-gated sodium channels by TNF-α during herpes simplex virus latency establishment3
Neuropsychological profile of patients with infectious disease: characterization and comparison of patients with HIV, HTLV, and HCV3
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases3
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD43
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV3
A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry3
Single nucleotide polymorphisms in aquaporin-4 associate with cognitive impairment status in people with HIV3
The synergistic effect of insomnia and depression on risk of herpes zoster3
Reactivation of varicella zoster virus following trigeminal schwannoma resection3
Does antiretroviral therapy alter the course of Parkinson’s disease in people living with HIV?3
RNA-Seq time-course analysis of neural precursor cell transcriptome in response to herpes simplex Virus-1 infection3
SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell–derived human neurons3
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis3
Neuropsychiatric disorders in the course to SARS-CoV-2 virus infection, including biological pathomechanisms, psychosocial factors and long COVID-19 associated with “brain fog”3
Role of inflammatory cytokine burst in neuro-invasion of Japanese Encephalitis virus infection: an immunotherapeutic approaches3
Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR3
Central nervous system reactivation of herpesviridae family in patients with COVID-193
High glucose potentiates Zika virus induced-astroglial dysfunctions3
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells3
A viral attack on brain tumors: the potential of oncolytic virus therapy3
The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV2
Clinical use of steroids in viral central nervous system (CNS) infections: three challenging cases2
Neuropathies and neurological dysfunction induced by coronaviruses2
Disruption of blood–brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins2
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial2
Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling2
Assessing cognitive impairment in HIV-infected: a comparative study of international HIV Dementia Scale, HIV Dementia Scale Italian version and Montreal cognitive assessment in clinical practice2
CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study2
Guillain-Barré syndrome associated with COVID-19: a case report study2
Immune-mediated cerebellitis following SARS-CoV-2 infection—a case report and review of the literature2
A case of trigeminal neuralgia developing after a COVID-19 vaccination2
Induced expression of rabies glycoprotein in the dorsal hippocampus enhances hippocampal dependent memory in a rat model of Alzheimer’s disease2
Caffeine upregulates SIRT3 expression to ameliorate astrocytes-mediated HIV-1 Tat neurotoxicity via suppression of EGR1 signaling pathway2
Multi-functional auto-fluorescent nanogels for theranostics2
Risk factors of herpes simplex virus reactivation after surgery for primary trigeminal neuralgia2
Correction: Performance of the national institute of infectious diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis2
Norovirus-associated neurological manifestations: summarizing the evidence2
Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo2
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology2
Cerebrospinal fluid CD14++CD16+ monocytes in HIV-1 subtype C compared with subtype B2
Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression2
Persistent accelerated epigenetic ageing in a longitudinal cohort of vertically infected HIV-positive adolescents2
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab2
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections2
Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies2
Influenza vaccination status in multiple sclerosis patients from Latin America2
Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder2
Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from Iran2
HIV viremia contributes to neurocognitive impairments in persons who use cocaine2
Susac syndrome complicating a SARS-CoV-2 infection2
Cognitive dysfunction following COVID-19 infection2
Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice2
0.074285984039307